SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-17-367440
Filing Date
2017-12-12
Accepted
2017-12-12 16:06:40
Documents
10

Document Format Files

Seq Description Document Type Size
1 424B3 d500230d424b3.htm 424B3 482208
2 GRAPHIC g500230g09l17.jpg GRAPHIC 81703
3 GRAPHIC g500230g15a71.jpg GRAPHIC 94190
4 GRAPHIC g500230g17x87.jpg GRAPHIC 38365
5 GRAPHIC g500230g36s64.jpg GRAPHIC 46911
6 GRAPHIC g500230g48t15.jpg GRAPHIC 88115
7 GRAPHIC g500230g64x21.jpg GRAPHIC 59450
8 GRAPHIC g500230g74h94.jpg GRAPHIC 69215
9 GRAPHIC g500230g91a07.jpg GRAPHIC 58638
10 GRAPHIC g500230g91t90.jpg GRAPHIC 113609
  Complete submission text file 0001193125-17-367440.txt   1379989
Mailing Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142 (844) 902-6100
Acer Therapeutics Inc. (Filer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-208314 | Film No.: 171251837
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1